• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

他汀类药物通过减少病毒粒子组装来降低登革热病毒的产生。

Statins reduce dengue virus production via decreased virion assembly.

机构信息

Programa de Estudio y Control de Enfermedades Tropicales, Medellín, Colombia.

出版信息

Intervirology. 2011;54(4):202-16. doi: 10.1159/000321892. Epub 2011 Feb 4.

DOI:10.1159/000321892
PMID:21293097
Abstract

BACKGROUND

Most of the effects of statins can be explained by pleiotropic effects independent of their lowering of serum cholesterol; in some cases, these effects have been shown to be a result of the role of statins in the prenylation of cellular proteins, some of which are involved in the life cycle of animal viruses. This study evaluated the potential antiviral activity of lovastatin (LOV) against dengue virus (DENV) infection of epithelial and endothelial cells (VERO cells, epithelial cells derived from African green monkey kidney, and HMEC-1 cells, human dermal microvascular endothelial cells).

METHODS

To evaluate its potential antiviral effects, LOV was used before, during and after inoculation of cell cultures with DENV.

RESULTS

Before and after viral inoculation, LOV caused a reduction in virus yield (80% for HMECs and 25% for VERO cells). However, with LOV treatment after inoculation induced a marked increase (2- to 9-fold) in viral-positive RNA while the amount of viral protein increased only by 13-23%. A moderate reduction (1 log unit) in viral titer occurred concurrent with the increase in DENV genomic RNA and protein within the cells.

CONCLUSIONS

According to our results, LOV appears to have a greater effect on viral assembly than on replication, resulting in the cellular presence of viral genomic RNA and proteins that fail to take the normal assembly pathway.

摘要

背景

他汀类药物的大多数作用可以通过独立于降低血清胆固醇的多效作用来解释;在某些情况下,这些作用已被证明是他汀类药物在细胞蛋白的prenylation 中的作用的结果,其中一些参与动物病毒的生命周期。本研究评估了洛伐他汀(LOV)对上皮细胞和内皮细胞(VERO 细胞,源自非洲绿猴肾的上皮细胞和 HMEC-1 细胞,人真皮微血管内皮细胞)中登革热病毒(DENV)感染的潜在抗病毒活性。

方法

为了评估其潜在的抗病毒作用,在接种 DENV 前后以及接种后使用 LOV 处理细胞培养物。

结果

病毒接种前后,LOV 导致病毒产量减少(对 HMEC 为 80%,对 VERO 细胞为 25%)。然而,接种后用 LOV 处理会导致病毒阳性 RNA 显著增加(HMEC 为 2-9 倍,VERO 细胞为 2-9 倍),而病毒蛋白的量仅增加 13-23%。与细胞内 DENV 基因组 RNA 和蛋白质的增加同时发生病毒滴度适度降低(1 个对数单位)。

结论

根据我们的结果,LOV 似乎对病毒组装的影响大于对复制的影响,导致细胞内存在无法采取正常组装途径的病毒基因组 RNA 和蛋白质。

相似文献

1
Statins reduce dengue virus production via decreased virion assembly.他汀类药物通过减少病毒粒子组装来降低登革热病毒的产生。
Intervirology. 2011;54(4):202-16. doi: 10.1159/000321892. Epub 2011 Feb 4.
2
Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus.去甲二氢愈创木酸(NDGA)抑制登革病毒的复制和病毒形态发生。
Antiviral Res. 2014 Sep;109:132-40. doi: 10.1016/j.antiviral.2014.07.002. Epub 2014 Jul 11.
3
Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection.碳水化合物结合剂的抗病毒活性及DC-SIGN在登革病毒感染中的作用
Virology. 2009 Apr 25;387(1):67-75. doi: 10.1016/j.virol.2009.01.043. Epub 2009 Mar 4.
4
In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.利用登革热病毒包膜 E 蛋白对小分子文库进行计算机筛选,发现了具有抗多种黄病毒活性的化合物。
Antiviral Res. 2009 Dec;84(3):234-41. doi: 10.1016/j.antiviral.2009.09.007. Epub 2009 Sep 23.
5
The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell.硫酸化多糖对登革病毒的抗病毒活性取决于病毒血清型和宿主细胞。
Antiviral Res. 2005 Jun;66(2-3):103-10. doi: 10.1016/j.antiviral.2005.02.001. Epub 2005 Feb 26.
6
Lovastatin delays infection and increases survival rates in AG129 mice infected with dengue virus serotype 2.洛伐他汀可延迟登革病毒 2 型感染的 AG129 小鼠的感染并提高存活率。
PLoS One. 2014 Feb 21;9(2):e87412. doi: 10.1371/journal.pone.0087412. eCollection 2014.
7
In vitro inhibition of dengue virus entry by p-sulfoxy-cinnamic acid and structurally related combinatorial chemistries.对-亚磺酰氧基肉桂酸及结构相关组合化学物对登革病毒进入的体外抑制作用
Antiviral Res. 2008 Nov;80(2):135-42. doi: 10.1016/j.antiviral.2008.05.007. Epub 2008 Jun 13.
8
Stimulation of dengue virus replication in cultured Aedes albopictus (C6/36) mosquito cells by the antifungal imidazoles ketoconazole and miconazole.抗真菌咪唑类药物酮康唑和咪康唑对培养的白纹伊蚊(C6/36)蚊细胞中登革病毒复制的刺激作用。
Virology. 2000 Mar 30;269(1):1-6. doi: 10.1006/viro.2000.0217.
9
Ultrastructural aspects of the dengue virus (flavivirus) particle morphogenesis.登革病毒(黄病毒属)颗粒形态发生的超微结构特征。
J Submicrosc Cytol Pathol. 1999 Jul;31(3):407-12.
10
Changes in antiviral susceptibility to entry inhibitors and endocytic uptake of dengue-2 virus serially passaged in Vero or C6/36 cells.在 Vero 或 C6/36 细胞中连续传代的登革热 2 型病毒对进入抑制剂的抗病毒敏感性和内吞摄取的变化。
Virus Res. 2014 May 12;184:39-43. doi: 10.1016/j.virusres.2014.02.011. Epub 2014 Feb 25.

引用本文的文献

1
Novel and repurposed antiviral molecules for arbovirus infections with epidemic Potential: A systematic review.用于具有流行潜力的虫媒病毒感染的新型及重新利用的抗病毒分子:一项系统综述。
New Microbes New Infect. 2025 Jul 10;66:101614. doi: 10.1016/j.nmni.2025.101614. eCollection 2025 Aug.
2
The endoplasmic reticulum (ER): a crucial cellular hub in flavivirus infection and potential target site for antiviral interventions.内质网(ER):黄病毒感染中的关键细胞枢纽及抗病毒干预的潜在靶点。
Npj Viruses. 2024 Jun 21;2(1):24. doi: 10.1038/s44298-024-00031-7.
3
Drug repositioning as a promising approach for the eradication of emerging and re-emerging viral agents.
药物重新定位作为一种有前景的方法,用于根除新出现和再次出现的病毒病原体。
Mol Divers. 2025 Mar 18. doi: 10.1007/s11030-025-11131-8.
4
Dengue virus and lipid metabolism: unravelling the interplay for future therapeutic approaches.登革病毒与脂质代谢:揭示两者相互作用以探索未来治疗方法
Emerg Microbes Infect. 2025 Dec;14(1):2477647. doi: 10.1080/22221751.2025.2477647. Epub 2025 Apr 9.
5
The importance of paying attention to the role of lipid-lowering drugs in controlling dengue virus infection.重视降脂药物在控制登革病毒感染中作用的重要性。
Virol J. 2024 Dec 19;21(1):324. doi: 10.1186/s12985-024-02608-3.
6
The Mechanism of Action of L-Tyrosine Derivatives against Chikungunya Virus Infection In Vitro Depends on Structural Changes.L-酪氨酸衍生物抗基孔肯雅病毒感染的作用机制体外依赖于结构变化。
Int J Mol Sci. 2024 Jul 21;25(14):7972. doi: 10.3390/ijms25147972.
7
Potential use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition and prevention method in viral infection.前蛋白转化酶枯草溶菌素 9(PCSK9)抑制的潜在用途及病毒感染的预防方法。
Microb Cell Fact. 2024 Mar 25;23(1):90. doi: 10.1186/s12934-024-02355-8.
8
Severe dengue in the intensive care unit.重症监护病房中的严重登革热。
J Intensive Med. 2023 Sep 28;4(1):16-33. doi: 10.1016/j.jointm.2023.07.007. eCollection 2024 Jan.
9
Lipid compartments and lipid metabolism as therapeutic targets against coronavirus.脂质区室和脂质代谢作为对抗冠状病毒的治疗靶点。
Front Immunol. 2023 Dec 1;14:1268854. doi: 10.3389/fimmu.2023.1268854. eCollection 2023.
10
An ivermectin - atorvastatin combination impairs nuclear transport inhibiting dengue infection and .伊维菌素与阿托伐他汀联合使用会损害核转运,从而抑制登革热感染。
iScience. 2023 Oct 27;26(12):108294. doi: 10.1016/j.isci.2023.108294. eCollection 2023 Dec 15.